W R Bell, A G Meek. Show Affiliations »
Abstract
Mesh: See more » ChildDrug Hypersensitivity/etiologyEndopeptidases/therapeutic useFemaleHemorrhage/chemically inducedHemorrhage/therapyHumansPlasminogen Activators/metabolismPregnancyPulmonary Embolism/drug therapyStreptokinase/administration & dosageStreptokinase/adverse effectsStreptokinase/therapeutic useThrombin TimeThromboembolism/drug therapyThrombophlebitis/drug therapyUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/adverse effectsUrokinase-Type Plasminogen Activator/therapeutic use
Substances: See more » EndopeptidasesStreptokinasePlasminogen ActivatorsUrokinase-Type Plasminogen Activator
Year: 1979 PMID: 503130 DOI: 10.1056/NEJM197912063012305
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245